Akili Inc Alpha and Beta Analysis
| AKLIDelisted Stock | USD 0.43 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Akili Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Akili over a specified time horizon. Remember, high Akili's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Akili's market risk premium analysis include:
Beta 0.1 | Alpha 0.92 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Akili |
Akili Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Akili market risk premium is the additional return an investor will receive from holding Akili long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Akili. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Akili's performance over market.| α | 0.92 | β | 0.10 |
Akili Fundamentals Vs Peers
Comparing Akili's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Akili's direct or indirect competition across all of the common fundamentals between Akili and the related equities. This way, we can detect undervalued stocks with similar characteristics as Akili or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Akili's fundamental indicators could also be used in its relative valuation, which is a method of valuing Akili by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Akili to competition |
| Fundamentals | Akili | Peer Average |
| Return On Equity | -0.68 | -0.31 |
| Return On Asset | -0.37 | -0.14 |
| Operating Margin | (28.37) % | (5.51) % |
| Current Valuation | (15.56 M) | 16.62 B |
| Shares Outstanding | 78.73 M | 571.82 M |
| Shares Owned By Insiders | 23.21 % | 10.09 % |
| Shares Owned By Institutions | 61.47 % | 39.21 % |
Akili Opportunities
Akili Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Akili, Inc. Short Interest Down 35.4 percent in April - Defense World | 04/26/2024 |
2 | Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results | 04/30/2024 |
3 | Disposition of 1840 shares by Studer Jacqueline of Akili at 0.4088 subject to Rule 16b-3 | 05/06/2024 |
4 | Akili Reports First Quarter 2024 Financial Results and Provides Business Update | 05/14/2024 |
5 | Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company | 05/29/2024 |
6 | SHAREHOLDER INVESTIGATION The MA Class Action Firm Announces An Investigation of the Merger and its ... - PR Newswire | 06/04/2024 |
7 | Disposition of 5118 shares by Studer Jacqueline of Akili at 0.4227 subject to Rule 16b-3 | 06/07/2024 |
8 | Financial Comparison Akili and Tandem Diabetes Care - Defense World | 06/20/2024 |
9 | Virtual Therapeutics Announces Results of Tender Offer to Acquire Akili Interactive | 07/02/2024 |
About Akili Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Akili or other delisted stocks. Alpha measures the amount that position in Akili Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Akili Upcoming Company Events
As portrayed in its financial statements, the presentation of Akili's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akili's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Akili's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Akili. Please utilize our Beneish M Score to check the likelihood of Akili's management manipulating its earnings.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Akili
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |